Stanford University
Showing 18,401-18,450 of 35,002 Results
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Norman Lowenbraun
Member, Cardiovascular Institute
BioDr Lowenbraun has been a practicing cardiologist in the Bay Area for over 25 years, having moved here after receiving his medical and specialty training on the East Coast. He believes offering the personal care of a community setting and empowering the patient in their healthcare decisions, combined with the resources of Stanford Hospital , offers his patients the best of both worlds.
-
Henry Lowood
Harold C. Hohbach Curator - History of Science & Technology; Film & Media, Humanities Resource Group
Current Role at StanfordHarold C. Hohbach Curator, Stanford Libraries
-
Katherine Lowry
Affiliate, Central Mgmt-Misc AR
BioKatherine Lowry is the Advanced Practice Provider Manager for the Lucile Packard Children's Hospital and Stanford Health Care nurse anesthesia and Stanford Health Care robotic surgery first assistant providers.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Trevor Loy
Instructor, Stanford Engineering Center for Global and Online Education
BioTrevor Loy is the Managing Partner and Founder of Flywheel Ventures, a seed- and early-stage venture capital firm that has invested in emerging startup ecosystems for more than twenty-five years.
As an Adjunct Lecturer at Stanford, Trevor teaches entrepreneurial management and finance in the Management Science & Engineering Department, where he is affiliated with the Stanford Technology Ventures Program, a research and teaching center he helped create as a graduate student. He also teaches professional and executive education programs for the Stanford Engineering Center for Global & Online Education, as well as for global companies, universities, governments, and sovereign wealth funds.
Trevor shapes venture capital and entrepreneurship policy as a former director of the National Venture Capital Association and a current member of its Board Alumni Council. He also served as Chair of VenturePAC, the venture capital industry's national political action committee, and is a frequent expert witness in private litigation and government policymaking worldwide.
Before founding Flywheel, Trevor held founding, executive, and technical roles at startups including Brooktree, Gigabeat, and ParkingNet, as well as at large tech firms such as Intel, Rockwell, and Teradyne.
He holds a BS and MS in Electrical Engineering and an MS in Management Science & Engineering, all from Stanford University. -
Prashant Loyalka
Associate Professor of Education and Senior Fellow at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsPrashant's research focuses on examining/addressing inequalities in the education of youth and on understanding/improving the quality of education received by youth in a number of countries including China, India, Russia, and the United States. In the course of addressing educational inequalities, Prashant examines the consequences of tracking, financial and informational constraints, as well as social and psychological factors in highly competitive education systems. His work on understanding educational quality is built around research that assesses and compares student learning in higher education, high school and compulsory schooling. He furthermore conducts large-scale evaluations of educational programs and policies that seek to improve student outcomes.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Donghui Lu
Senior Scientist, Stanford Synchrotron Radiation Lightsource
BioDonghui Lu is a senior scientist at SLAC National Accelerator Laboratory. He is the deputy director of the Materials Science Division at the Stanford Synchrotron Radiation Lightsource leading the Soft X-ray Group. His research interests lie in studying quantum materials, such as high temperature superconductors, using high resolution angle-resolved photoemission spectroscopy. He is also an expert in developing modern synchrotron instrumentations, including cutting-edge soft x-ray beamlines and sophisticated endstations with versatile sample environments and materials synthesis capabilities.
-
Lu,Guolan
Assistant Professor of Urology
Current Research and Scholarly InterestsThe Lu Lab develops spatial omics and computational methods to measure, model, and predict how cells, tissues, and therapeutic agents interact in their native spatial context, and how these interactions drive disease progression and treatment response.
-
Janice Lu
Clinical Professor, Medicine - Oncology
BioDr. Janice Lu is Clinical Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. She specializes in the treatment of breast cancer, with expertise in hormone receptor–positive and HER2-positive disease, antibody-drug conjugates, and immunotherapy. Dr. Lu has led and contributed to multiple clinical trials, including playing a key role in the EMERALD trial, which resulted in FDA approval of the first oral SERD for ESR1-mutated ER+/HER2- metastatic breast cancer. Her translational research focuses on liquid biopsy, epigenetics, AI and multiomics approaches to treatment resistance. She has chaired national sessions on precision oncology and holds leadership roles with NRG Oncology and ASCO, including Vice-Chair of the NRG Immunotherapy Subcommittee and Track Leader for ASCO’s Developmental Therapeutics and Targeted Therapy Education Program. She has also served on committees for the National Comprehensive Cancer Network (NCCN) and the Southwest Oncology Group (SWOG).
Dr. Lu completed her Hematology and Oncology fellowship at New York University School of Medicine and earned a PhD in epigenetics under the mentorship of late Dr. David Allis, a pioneer in the field and 2018 Lasker Laureate. Prior to joining Stanford, she was Director of Breast Medical Oncology and led the Circulating Tumor Cell (CTC) Core Lab at Northwestern University Feinberg School of Medicine, before returning to the Bay Area to be with her family and to further expand research and patient-centered care. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms.
